Literature DB >> 30099260

Long-acting liposomal corneal anesthetics.

Changyou Zhan1, Claudia M Santamaria2, Weiping Wang2, J Brian McAlvin2, Daniel S Kohane3.   

Abstract

Eye drops producing long-acting ocular anesthesia would be desirable for corneal pain management. Here we present liposome-based formulations to achieve very long ocular anesthetic effect after a single eye drop instillation. The liposomes were functionalized with succinyl-Concanavalin A (sConA-Lip), which can bind corneal glycan moieties, to significantly prolong the dwell time of liposomes on the cornea. sConA-Lip were loaded with tetrodotoxin and dexmedetomidine (sConA-Lip/TD), and provided sustained release for both. A single topical instillation of sConA-Lip/TD on the cornea could achieve 105 min of complete analgesia and 608 min of partial analgesia, which was significantly longer than analgesia with proparacaine, tetrodotoxin/dexmedetomidine solution or unmodified liposomes containing tetrodotoxin and dexmedetomidine. sConA-Lip/TD were not cytotoxic in vitro to human corneal limbal epithelial cells or corneal keratocytes. Topical administration of sConA-Lip/TD provided prolonged corneal anesthesia without delaying corneal wound healing. Such a formulation may be useful for the management of acute surgical and nonsurgical corneal pain, or for treatment of other ocular surface diseases.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  Concanavalin A; Dexmedetomidine; Liposome; Ocular anesthesia; Tetrodotoxin

Mesh:

Substances:

Year:  2018        PMID: 30099260      PMCID: PMC7482074          DOI: 10.1016/j.biomaterials.2018.07.054

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  42 in total

1.  Essentials of local anesthetic pharmacology.

Authors:  Daniel E Becker; Kenneth L Reed
Journal:  Anesth Prog       Date:  2006

2.  Localization of lectin binding sites in human, cat, and rabbit corneas.

Authors:  N Panjwani; P Moulton; J Alroy; J Baum
Journal:  Invest Ophthalmol Vis Sci       Date:  1986-08       Impact factor: 4.799

Review 3.  Liposomes: versatile and biocompatible nanovesicles for efficient biomolecules delivery.

Authors:  Sudipta Mallick; Joon Sig Choi
Journal:  J Nanosci Nanotechnol       Date:  2014-01

4.  Effect of lectins on migration of the corneal epithelium.

Authors:  I K Gipson; R A Anderson
Journal:  Invest Ophthalmol Vis Sci       Date:  1980-04       Impact factor: 4.799

5.  Ultrasensitive Phototriggered Local Anesthesia.

Authors:  Changyou Zhan; Weiping Wang; Claudia Santamaria; Bruce Wang; Alina Rwei; Brian P Timko; Daniel S Kohane
Journal:  Nano Lett       Date:  2017-01-06       Impact factor: 11.189

6.  Theranostic Liposomes with Hypoxia-Activated Prodrug to Effectively Destruct Hypoxic Tumors Post-Photodynamic Therapy.

Authors:  Liangzhu Feng; Liang Cheng; Ziliang Dong; Danlei Tao; Todd E Barnhart; Weibo Cai; Meiwan Chen; Zhuang Liu
Journal:  ACS Nano       Date:  2016-12-29       Impact factor: 15.881

7.  Topical drug formulations for prolonged corneal anesthesia.

Authors:  Liqiang Wang; Sahadev A Shankarappa; Rong Tong; Joseph B Ciolino; Jonathan H Tsui; Homer H Chiang; Daniel S Kohane
Journal:  Cornea       Date:  2013-07       Impact factor: 2.651

8.  Liposomal amphotericin B eye drops to treat fungal keratitis: physico-chemical and formulation stability.

Authors:  K Morand; A C Bartoletti; A Bochot; G Barratt; M L Brandely; F Chast
Journal:  Int J Pharm       Date:  2007-05-06       Impact factor: 5.875

9.  Prolongation of corneal allograft survival with liposome-encapsulated cyclosporine in the rat eye.

Authors:  J K Milani; U Pleyer; A Dukes; H J Chou; S Lutz; D Rückert; K H Schmidt; B J Mondino
Journal:  Ophthalmology       Date:  1993-06       Impact factor: 12.079

10.  Sustained release of an anti-glaucoma drug: demonstration of efficacy of a liposomal formulation in the rabbit eye.

Authors:  Jayaganesh V Natarajan; Sujay Chattopadhyay; Marcus Ang; Anastasia Darwitan; Selin Foo; Ma Zhen; Magdalene Koo; Tina T Wong; Subbu S Venkatraman
Journal:  PLoS One       Date:  2011-09-09       Impact factor: 3.240

View more
  6 in total

1.  Sevoflurane Exerts an Anti-depressive Action by Blocking the HMGB1/TLR4 Pathway in Unpredictable Chronic Mild Stress Rats.

Authors:  Zhenggang Guo; Feng Zhao; Ye Wang; Ye Wang; Miaomiao Geng; Yilei Zhang; Qingxia Ma; Xiuzheng Xu
Journal:  J Mol Neurosci       Date:  2019-07-31       Impact factor: 3.444

2.  Topical anesthetic analgesic therapy using the combination of ropivacaine and dexmedetomidine: hyaluronic acid modified long-acting nanostructured lipid carriers containing a skin penetration enhancer.

Authors:  Yongjian Yang; Dahai Qiu; Yajun Liu; Lei Chao
Journal:  Drug Des Devel Ther       Date:  2019-09-18       Impact factor: 4.162

Review 3.  Nanocarriers for ocular drug delivery: current status and translational opportunity.

Authors:  Srividya Gorantla; Vamshi Krishna Rapalli; Tejashree Waghule; Prem Prakash Singh; Sunil Kumar Dubey; Ranendra N Saha; Gautam Singhvi
Journal:  RSC Adv       Date:  2020-07-24       Impact factor: 4.036

4.  Tacrolimus Loaded Cationic Liposomes for Dry Eye Treatment.

Authors:  Xiang Chen; Jicheng Wu; Xueqi Lin; Xingdi Wu; Xuewen Yu; Ben Wang; Wen Xu
Journal:  Front Pharmacol       Date:  2022-02-04       Impact factor: 5.810

5.  Enhanced Antitumor Activity of Lidocaine Nanoparticles Encapsulated by a Self-Assembling Peptide.

Authors:  Yang Yang; Jiaxiao Sun; Fei Peng; Haibei Liu; Guoyan Zhao; Junjie Chen; Wensheng Zhang; Feng Qiu
Journal:  Front Pharmacol       Date:  2022-04-21       Impact factor: 5.988

Review 6.  Ocular Nanomedicine.

Authors:  Zhimin Tang; Xianqun Fan; Yu Chen; Ping Gu
Journal:  Adv Sci (Weinh)       Date:  2022-02-12       Impact factor: 17.521

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.